Related Experiment Video
Updated: Feb 3, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Role of viral load in Hepatitis B virus evolution in persistently normal ALT chronically infected patients
C Gauder1, L N Mojsiejczuk2, L Tadey3
1Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología y Biotecnología, Cátedra de Virología, Junín 956 4to piso, Ciudad Autónoma de Buenos Aires, Argentina.
Insights
Chronic Hepatitis B virus (HBV) infection shows faster molecular evolution in patients with low viral loads. Immune pressure on the HBV Core region drives these evolutionary changes, even in low replicative states.
Area of Science:
- Virology
- Molecular Evolution
- Hepatology
Background:
- Chronic Hepatitis B virus (HBV) infection is a global health concern, often leading to severe liver disease.
- Low replicative carriers represent the largest HBV-infected population, yet longitudinal studies on their molecular evolution are scarce.
- Understanding HBV intra-host dynamics is crucial for managing chronic infection.
Purpose of the Study:
- To investigate the molecular evolution of the whole HBV genome in chronically infected patients with persistently normal ALT levels over a 10-year period.
- To determine the relationship between HBV DNA levels and the rate of nucleotide substitution.
- To identify specific HBV regions influenced by viral load and potential immune pressure.
Main Methods:
- Longitudinal sampling from 10 patients with normal ALT levels over 10 years.
- Sequencing of HBV full-length genomes from baseline, 5-year, and 10-year follow-up samples.
- Grouping patients based on HBV DNA levels (<10^3 IU/ml vs. >10^3 IU/ml) and analyzing substitution rates.
Main Results:
- The rate of nucleotide substitution was inversely related to HBV DNA levels.
- Group A (<10^3 IU/ml) exhibited a significantly higher substitution rate (6.9 × 10^-4) than Group B (>10^3 IU/ml) (2.7 × 10^-4) over 10 years (p < .001).
- Most substitutions occurred in the Core region, particularly in coding and antigenic epitope regions, suggesting immune-driven evolution.
Conclusions:
- Viral load plays a significant role in HBV intra-host dynamics, even in low replicative states.
- The Core region is a key driver of HBV evolutionary differences between patients with varying viral loads.
- Immune pressure likely influences the distinct evolutionary trajectories observed in chronically infected individuals.
Abstract:
Chronic HBV infection has been associated with severe liver disease although most of them do not progress to this stage. Even though low replicative carriers form the largest group of HBV chronically infected patients, there is a paucity of longitudinal studies to evaluate the molecular evolution of the whole genome in this subset of patients. In this study, longitudinal samples from 10 patients with persistently normal ALT levels were collected. HBV full-length genome sequences were obtained from 3 samples per patient (baseline, 5 and 10-years of follow-up). Patients were grouped according to HBV-DNA level into <103 IU/ml (group A) or > 103 IU/ml (group B). The substitution rate was inversely related with HBV-DNA levels. Moreover, the rate in the 10-year follow-up was significantly higher in group A (6.9 × 10-4 ± 1.3 × 10-4) than group B (2.7 × 10-4 ± 7.4 × 10-5 substitution/site/year, p < .001). Most of the substitutions were in the Core region and the majority were non-synonymous changes. The rate of nucleotide substitution was inversely related to HBV-DNA levels, highlighting the role of viral load in the HBV intra-host dynamics, even in low replicative state patients. Moreover, the difference in the substitution rate between the analysed groups was mainly consequence of substitutions restricted to the Core region, particularly in the simple coding region and antigenic epitopes, which suggest that the immune pressure drives the different evolutionary behaviour of groups.
Related Concept Videos
Normal Strain under Axial Loading
Convergent Evolution
Hepatic Drug Clearance: Role of Transporters
Viral Recombination
The Evidence for Evolution
What are Viruses?

